Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.41B |
| 2 |
American Tower
AMT
|
+$272M |
| 3 |
Microsoft
MSFT
|
+$271M |
| 4 |
Zoom
ZM
|
+$245M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TIF
Tiffany & Co.
TIF
|
+$206M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
+$200M |
| 3 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$186M |
| 4 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$151M |
| 5 |
Pfizer
PFE
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.25% |
| 2 | Healthcare | 13.6% |
| 3 | Financials | 13.05% |
| 4 | Consumer Discretionary | 12.39% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Astrana Health
ASTH
$1.71B
| $5.51M | ﹤0.01% |
301,559
+6,975
| +2% | +$125K |
|
2552
Farmers National Banc Corp
FMNB
$938M
| $5.51M | ﹤0.01% |
414,962
-685
| -0.2% | -$8.56K |
|
2553
Viking Therapeutics
VKTX
$3.89B
| $5.48M | ﹤0.01% |
973,688
+24,890
| +3% | +$151K |
|
2554
Expro Ltd
XPRO
$1.92B
| $5.48M | ﹤0.01% |
333,360
+26,771
| +9% | +$350K |
|
2555
Amerant Bancorp
AMTB
$1.14B
| $5.48M | ﹤0.01% |
360,463
+1,419
| +0.4% | +$18.4K |
|
|
BLDP
2556
Ballard Power Systems
BLDP
$772M
| $5.48M | ﹤0.01% |
234,087
+5,249
| +2% | +$96.7K |
|
2557
Hanmi Financial
HAFC
$955M
| $5.48M | ﹤0.01% |
483,072
-7,194
| -1% | -$72K |
|
|
AD
2558
Array Digital Infrastructure
AD
$3.1B
| $5.45M | ﹤0.01% |
177,730
+9,962
| +6% | +$303K |
|
2559
DXP Enterprises
DXPE
$2.95B
| $5.44M | ﹤0.01% |
244,703
-4,879
| -2% | -$98.6K |
|
2560
Novartis
NVS
$293B
| $5.43M | ﹤0.01% |
57,487
+5,672
| +11% | +$496K |
|
2561
Puma Biotechnology
PBYI
$408M
| $5.4M | ﹤0.01% |
526,339
-11,546
| -2% | -$117K |
|
2562
Sotera Health
SHC
$5.41B
| $5.39M | ﹤0.01% |
+196,615
| New | +$5.28M |
|
|
ORC
2563
Orchid Island Capital
ORC
$1.28B
| $5.39M | ﹤0.01% |
206,692
+13,050
| +7% | +$346K |
|
2564
Precision BioSciences
DTIL
$190M
| $5.39M | ﹤0.01% |
21,551
+1,577
| +8% | +$387K |
|
2565
Cue Biopharma
CUE
$115M
| $5.39M | ﹤0.01% |
14,355
+1,301
| +10% | +$520K |
|
2566
Organogenesis Holdings
ORGO
$306M
| $5.39M | ﹤0.01% |
715,452
+335,098
| +88% | +$1.59M |
|
|
CIVI
2567
DELISTED
Civitas Resources
CIVI
| $5.38M | ﹤0.01% |
278,341
+10,738
| +4% | +$226K |
|
|
CPRX
2568
DELISTED
Catalyst Pharmaceutical
CPRX
| $5.35M | ﹤0.01% |
1,602,694
+54,666
| +4% | +$184K |
|
|
TBRG
2569
DELISTED
TruBridge
TBRG
| $5.34M | ﹤0.01% |
198,861
+2,312
| +1% | +$65.3K |
|
2570
SunCoke Energy
SXC
$819M
| $5.32M | ﹤0.01% |
1,223,915
+5,911
| +0.5% | +$24.7K |
|
|
DMTK
2571
DELISTED
DermTech, Inc. Common Stock
DMTK
| $5.32M | ﹤0.01% |
164,042
+25,480
| +18% | +$361K |
|
2572
First Community Bankshares
FCBC
$917M
| $5.31M | ﹤0.01% |
245,897
+2,653
| +1% | +$55.6K |
|
2573
The Joint Corp
JYNT
$118M
| $5.28M | ﹤0.01% |
201,236
+9,809
| +5% | +$224K |
|
|
MOFG
2574
DELISTED
MidWestOne Financial Group
MOFG
| $5.27M | ﹤0.01% |
215,182
+5,905
| +3% | +$135K |
|
2575
Hingham Institution for Saving
HIFS
$658M
| $5.26M | ﹤0.01% |
24,377
+720
| +3% | +$153K |
|
Similar funds
Geode Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Geode Capital Management held 4,369 positions worth $596B, up 17% from $510B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q4 2020 filing shows 215 new, 3,067 increased, 650 reduced and 100 closed positions. Its largest new stake was Apartment Income REIT Corp.: 2,223,585 shares worth $85.4M. The largest sale was Tiffany & Co., an estimated $206M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q4 2020 buy was Apartment Income REIT Corp.: 2,223,585 shares worth $85.4M.
- Geode Capital Management added most to Tesla in Q4 2020, an estimated $2.41B increase.
- Geode Capital Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $131M.
- Geode Capital Management fully exited Tiffany & Co. in Q4 2020, selling an estimated $206M.
- Geode Capital Management's ten largest holdings make up 22% of its $596B portfolio in Q4 2020.
- Geode Capital Management opened 215 new positions and closed 100 in Q4 2020.
- Geode Capital Management's portfolio value rose 17% quarter-over-quarter to $596B.
Based on Geode Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.